Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Terahertz Imaging Technology for Curbing Counterfeit Drugs
TeraView a UK-based firm has developed the ‘Terahertz Imaging Technology’ which can help regulators and law enforcement agencies fight drug piracy and counterfeit drugs. The technology helps identify counterfeit drugs by generating the structure of tablet coatings and cores by scanning the tablets and comparing the results against a database of known tablet ‘fingerprints’.
Aurora B as an Anti-Cancer Drug Target
A novel class of drugs - being developed by a major pharmaceutical company - targets an enzyme that helps cells divide; in cancer, this enzyme, called Aurora B, goes into overdrive, possibly leading to uncontrolled and abnormal cell divisions.
MHC Class II UltimersT from ProImmune
MHC Class II Ultimers™ProImmune manufactures MHC Class II Ultimers™, a multimer technology with a superior peptide-linked planar design and optimized fluorochrome for immunologists who wish to detect and quantitate CD4+ antigen-spe
Millipore\'s innovative MobiusT Disposable TFF Assemblies
Millipore Corporation has announced the availability of new Mobius™ disposable TFF assemblies, which offer flexible, self-contained solutions that reduce validation efforts, increase process speed and mitigate risks. Mobius disposable TFT assemblies are being showcased at IBC Disposables for Biopharmaceutical Manufacturing conference, California.
COMPAS - New Technology for Determining the Cardiac Safety Profile of Drugs
A new technology has been launched to help the pharmaceutical industry better understand the cardiac safety profile of the drugs they are developing. It consists of a software called ‘COMPAS’ (which stands for Comprehensive Analysis of Repolarisation Signal) and unique ECG Biometrics. While the COMPAS software has been developed by the Heart Research Follow-up Program, a part of University of Rochester Medical Center, the ECG Biome
ARTEL\\\'s Latest Innovation to Optimize Automated Liquid Handlers
Measuring the performance of an automated liquid delivery device precisely and accurately requires verifying the performance of individual channel and dispenses using very small volumes of liquid. Also the process must be user-friendly, fast and robust for the laboratories to use it frequently without much downtime. In the past, several methods for such multi-channel equipment calibration have been used with varying degrees of success like gra
Pall Corporation's Flexible Containment System to Ensure Workers' Safety
To protect the workers and the surrounding environment from exposure to harmful compounds, Pall Corporation has introduced a flexible system, called GBK Containment system, which will ensure safe handling of potent compounds. As new and more hazardous APIs are entering the pipeline, companies are facing an increasing challenge to ensure their workers’ safety. It is estimated that about 5-10% of the commercially available drugs are highly
New Label Replacement Solution for Secondary Packaging
Labelling for secondary packaging traditionally involves self-adhesive, thermal transfer printed labels. The outer cases use large character inkjet printing to display the information. As an economic and innovative alternative, DataLase Technologies has introduced Casemark – a new label replacement solution that gives 30-50% of savings in cost for a medium volume line. In addition, the investment has a payb
New Approach to Manipulating GPCRs
G-protein-coupled receptors or GPCRs are the most important signalling mechanism in human cells. They react on exposure to the nutrients, toxins, hormones and light particles. The major blockbuster drugs target the GPCRs for treatment of many diseases including heart disease, cancer, diabetes, depression and arthritis. These drugs affect GPCRs behaviour external to the cells. Research scientists have devised a way
New Antibiotic by Merck that Fights Bacteria
In the present drug discovery scenario, there are very few pharmaceutical companies who invest in research into antibiotics, as majority prefer to focus on profitable drugs for chronic diseases. Most drugs were developed 50 years ago and older antibiotics have lost their effect as the bacteria have become resistant to them.
Merck has developed an antibiotic – platensim
